Logo image of DSY

BIG TREE CLOUD HOLDINGS LTD (DSY) Stock Fundamental Analysis

NASDAQ:DSY - Nasdaq - KYG1263B1086 - Common Stock - Currency: USD

1.25  -0.18 (-12.59%)

Fundamental Rating

1

Taking everything into account, DSY scores 1 out of 10 in our fundamental rating. DSY was compared to 35 industry peers in the Personal Care Products industry. DSY may be in some trouble as it scores bad on both profitability and health. DSY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DSY has reported negative net income.
In the past year DSY has reported a negative cash flow from operations.
DSY Yearly Net Income VS EBIT VS OCF VS FCFDSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K -1M

1.2 Ratios

DSY has a Return On Assets (0.21%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 0.25%, DSY is in line with its industry, outperforming 54.29% of the companies in the same industry.
Industry RankSector Rank
ROA 0.21%
ROE 0.25%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DSY Yearly ROA, ROE, ROICDSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 1 -1 2 -2

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DSY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DSY Yearly Profit, Operating, Gross MarginsDSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

DSY has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, DSY has a worse debt to assets ratio.
DSY Yearly Shares OutstandingDSY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M
DSY Yearly Total Debt VS Total AssetsDSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

DSY has an Altman-Z score of 10.03. This indicates that DSY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of DSY (10.03) is better than 85.71% of its industry peers.
DSY has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
DSY's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. DSY outperforms 62.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 10.03
ROIC/WACCN/A
WACCN/A
DSY Yearly LT Debt VS Equity VS FCFDSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 0.04 indicates that DSY may have some problems paying its short term obligations.
DSY has a Current ratio of 0.04. This is amonst the worse of the industry: DSY underperforms 97.14% of its industry peers.
DSY has a Quick Ratio of 0.04. This is a bad value and indicates that DSY is not financially healthy enough and could expect problems in meeting its short term obligations.
DSY has a Quick ratio of 0.04. This is amonst the worse of the industry: DSY underperforms 97.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
DSY Yearly Current Assets VS Current LiabilitesDSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

DSY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -121.18%.
EPS 1Y (TTM)-121.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-296.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DSY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DSY Price Earnings VS Forward Price EarningsDSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSY Per share dataDSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DSY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIG TREE CLOUD HOLDINGS LTD

NASDAQ:DSY (5/6/2025, 4:30:01 PM)

1.25

-0.18 (-12.59%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.25%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap71.35M
AnalystsN/A
Price TargetN/A
Short Float %0.23%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 2.3
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.21%
ROE 0.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 10.03
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-121.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-296.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-519.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-233.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-233.07%
OCF growth 3YN/A
OCF growth 5YN/A